Cornerstone Capital Management Holdings’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q4 | $885K | Buy |
19,098
+2,000
| +12% | +$92.7K | 0.01% | 921 |
|
|
2017
Q3 | $909K | Sell |
17,098
-1,100
| -6% | -$58.5K | 0.01% | 947 |
|
|
2017
Q2 | $1.13M | Buy |
18,198
+2,044
| +13% | +$127K | 0.01% | 879 |
|
|
2017
Q1 | $1.09M | Buy |
16,154
+8,237
| +104% | +$558K | 0.01% | 908 |
|
|
2016
Q4 | $556K | Sell |
7,917
-300
| -4% | -$21.1K | ﹤0.01% | 1069 |
|
|
2016
Q3 | $582K | Buy |
8,217
+3,786
| +85% | +$268K | ﹤0.01% | 1048 |
|
|
2016
Q2 | $216K | Hold |
4,431
| – | – | ﹤0.01% | 1190 |
|
|
2016
Q1 | $281K | Sell |
4,431
-1,000
| -18% | -$63.4K | ﹤0.01% | 1151 |
|
|
2015
Q4 | $609K | Buy |
5,431
+31
| +0.6% | +$3.48K | 0.01% | 998 |
|
|
2015
Q3 | $520K | Buy |
5,400
+1,000
| +23% | +$96.3K | ﹤0.01% | 1001 |
|
|
2015
Q2 | $451K | Buy |
+4,400
| New | +$451K | ﹤0.01% | 1032 |
|